Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Large-scale integration of cancer microarray data identifies a robust common cancer signature.

Large-scale integration of cancer microarray data identifies a robust common cancer signature. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Large-scale integration of cancer microarray data identifies a robust common cancer signature. Abstract Text:

    lei xuLei Xu,donald gemanDonald Geman,raimond l winslowRaimond L Winslow,

    BACKGROUND: There is a continuing need to develop molecular diagnostic tools which complement histopathologic examination to increase the accuracy of cancer diagnosis. DNA microarrays provide a means for measuring gene expression signatures which can then be used as components of genomic-based diagnostic tests to determine the presence of cancer. RESULTS: In this study, we collect and integrate ~1500 microarray gene expression profiles from 26 published cancer data sets across 21 major human cancer types. We then apply a statistical method, referred to as the Top-Scoring Pair of Groups (TSPG) classifier, and a repeated random sampling strategy to the integrated training data sets and identify a common cancer signature consisting of 46 genes. These 46 genes are naturally divided into two distinct groups; those in one group are typically expressed less than those in the other group for cancer tissues. Given a new expression profile, the classifier discriminates cancer from normal tissues by ranking the expression values of the 46 genes in the cancer signature and comparing the average ranks of the two groups. This signature is then validated by applying this decision rule to independent test data. CONCLUSION: By combining the TSPG method and repeated random sampling, a robust common cancer signature has been identified from large-scale microarray data integration. Upon further validation, this signature may be useful as a robust and objective diagnostic test for cancer.

    Large-scale integration of cancer microarray data identifies a robust common cancer signature. Publishing Authors By Initials

    l xuL Xu,d gemanD Geman,rl winslowRL Winslow,

    For similar biological factors: biological markers: tumor markers, biological research abstracts see: biological factors: biological markers: tumor markers, biological research

    PUBMED ID PMID:

    MEDLINE DATE:

    Large-scale integration of cancer microarray data identifies a robust common cancer signature. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: BMC bioinformatics

    VOLUME: 8

    Page Numbers: 275

    Journal Abbreviation: BMC Bioinformatics

    ISSN: 1471-2105

    DAY: 30

    MONTH: 07

    YEAR: 2007

    Large-scale integration of cancer microarray data identifies a robust common cancer signature. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100965194

    Large-scale integration of cancer microarray data identifies a robust common cancer signature. Keywords Mesh Terms:

    KEYWORDS: Tumor Markers, Biological

    MESH TERMS: analysis

    Chemical & Substance for Abstract: Large-scale integration of cancer microarray data identifies a robust common cancer signature. Information

    Substance Name: Tumor Markers, Biological

    Registry Number: 0

    Grant and Affiliation Information for Large-scale integration of cancer microarray data identifies a robust common cancer signature.

    AFFILIATION: The Institute for Computational Medicine and Center for Cardiovascular Bioinformatics and Modeling, Johns Hopkins University, Baltimore, MD 21218, USA. leixu@jhu.edu

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NHLBI

    GRANT: R01-HL72488

    ACRONYM: HL

    MEDLINETA: BMC Bioinformatics

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Large-scale integration of cancer microarray data identifies a robust common cancer signature Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News